Volume 2 - Issue 2, Winter 2008
- Cardio
- 21/12/2008
COVER STORY: This cover story looks at patient access to medical technology in Europe, and includes articles such as; “Access to Medical Technology...
READ MORE
Latest News articles in Cardio
-
-
Editorial
Dear Readers, Medical technology is constantly widening the diagnostic and therapeutic horizons in our professional lives. It provides hope for the patient who looks to the rapidly developing medical technology of tomorrow for a solution to his or her complex health problems today. Simultaneously, medical technology represents a remarkable...
READ MORE -
Access to Medical Technology Differs Across Europe:
Survey Shows Variety of Causes for Discrepancies Between Guidelines and Practice The practice of cardiovascular medicine differs from country to country despite commonly accepted management guidelines. Discrepancies persist, even when comparisons are based on investigations of the proportion of patients with a defined disease offered a particular...
READ MORE -
Review of Anticoagulants:
Improving the Management of Thromboembolitic Prevention in Routine Practice Anticoagulants are recommended for a wide variety of indications, including the prevention of venous thromboembolism (VTE; comprising deep vein thrombosis [DVT] and pulmonary embolism [PE]), the treatment of VTE, stroke prevention in patients with atrial fibrillation (AF)...
READ MORE -
Management Challenges of Cardiologists in Latvia: Taking Steps to Modernise Facilities
In the twenty years since the demise of the Soviet Union, Latvia has transformed itself, gaining its independence not only politically but also in medicine. While formerly, research, innovations and financial investments were concentrated in Moscow and less in the Baltic States, in present times Latvia is a member of the European Union, is independent,...
READ MORE -
CV Therapeutics Announces License Agreement
The Menari Group have been granted exclusive rights to Ranexa. The agreement grants rights to Menarini for Ranexa in 68 countries, including the 27 countries of the European Union, the Commonwealth of Independent States and certain countries in Central and South America. The deal included an upfront payment of 70 million dollars and further payments...
READ MORE -
EU Approves New Treatment
Tracleer®, a dual endothelin receptor antagonist has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (WHO FC II). A clinical study of patients with mildly symptomatic WHO FC II led to approval and revealed that even patients with mild symptoms are at risk of rapid deterioration....
READ MORE -
Radi Medical Systems Inc. Announces Clearance of Pressure Wire Certus
Previously only cleared for use in the coronary and peripheral blood vessels, PressureWire Certus can now be used to assess pressure measurements across heart valves and into various chambers of the heart. It can also be used in the assessment of Fractional Flow Reserve (FFR). FFR expresses the maximum achievable blood flow in a coronary artery with...
READ MORE -
St Jude Medical Announce Clearance of Implantable Device
The SJM Confirm™ implantable cardiac monitor (ICM) is a compact device designed to help physicians detect abnormal heart rhythms in patients with unexplained symptoms. It enables the evaluation of heart rhythm signals over a longer period of time compared to standard monitoring tests and it is the smallest ICM available which can be implanted in an...
READ MORE -
Cypher Sirolimus- Eluting Coronary Stent Comparable to Bypass Surgery
Cordis have released clinical data indicating that percutaneous coronary intervention with the CYPHER sirolimuseluting coronary stent is comparable to bypass surgery in key safety measures in patients with diabetes and multi-vessel disease. The data was recently presented at the European Society of Cardiology meeting. It is the only drug-eluting stent...
READ MORE
INFO
IMAGING
ICU
EXEC
IT
CARDIOLOGY
JOURNALS
EVENTS
FACULTY
PARTNERS
BLOG
VIDEOS
CONTACT US
EU Office
Rue Villain XIV 53-55
B-1050 Brussels, Belgium
Tel: +357 86 870 007
E-mail: [email protected]
EMEA & ROW Office
166, Agias Filaxeos
CY-3083, Limassol, Cyprus
Tel: +357 86 870 007
E-mail: [email protected]
Headquarters
Kosta Ourani, 5
Petoussis Court, 5th floor
CY-3085 Limassol, Cyprus
E-mail: [email protected]
HealthManagement.org © 2024 All rights reserved.